Regis Corp SEC Filings

Form 144 for RGS (Regis Corp) notifies the market of a proposed sale of 437 common shares through Fidelity Brokerage Services (900 Salem St, Smithfield, RI) with an approximate sale date of 09/26/2025. The filing reports the shares were acquired under an option granted 05/05/2022 and payment is indicated as cash. The issuer's total shares outstanding are listed as 2,435,981, giving the proposed block an aggregate market value of $12,454.50. The filer also reported recent sales by the same person: 9/18/2025 — 9,626 shares for $278,342.53 and 9/19/2025 — 937 shares for $26,719.49. The signer attests there is no undisclosed material adverse information.

Form 144 notice for Regis Corp (RGS) shows a proposed sale of 937 common shares through Fidelity Brokerage Services with an aggregate market value of $26,719.50, to be sold approximately on 09/19/2025 on NASDAQ. The filing lists 2,435,981 shares outstanding for the class and indicates the securities were acquired under options granted on 05/05/2022 with payment in cash.

The filing also discloses that the same person previously sold 9,626 common shares on 09/18/2025 for gross proceeds of $278,342.53. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information about the issuer.

Form 144 filed for Regis Corporation (RGS) reports a proposed sale of 9,626 shares of Common stock through Fidelity Brokerage Services with an aggregate market value of $278,342.33. The filing lists approximately 2,435,981 shares outstanding and an approximate sale date of 09/18/2025. The securities are shown as acquired in connection with an option (grant date 05/05/2022) and the indicated acquisition date is 09/18/2025; the consideration on sale is listed as cash. The filer states there were no securities sold by the person in the past three months and signs the required attestation that they are not aware of any undisclosed material adverse information about the issuer.

Regis Corporation outlines board refreshment, leadership transition, and strategic moves to improve company-owned salon performance. The company acquired 314 salons from Alline Salon Group, increasing its company-owned portfolio and creating a testing ground for customer and stylist initiatives. Regis reports stabilization of same-store sales and a return to profitable growth and has begun a relationship with a customer loyalty and engagement partner. CEO Matthew Doctor stepped down effective June 30, 2025; Jim Lain was named interim CEO effective July 1, 2025 and a Succession Planning Committee and external search firm are conducting a CEO search. The Board added Susan Lintonsmith and two long-serving directors, Mark Light and Ann Rhoades, are not seeking re-election. As of June 30, 2025, the Company franchised or owned 3,941 salons (3,647 franchised; 294 company-owned) and employed about 1,777 people. The proxy discloses a 1-for-20 reverse stock split (Nov 29, 2023), an increase in Purchase Plan shares from 227,500 to 377,500 (adding 150,000), a Sept 2, 2025 Nasdaq close of $22.11, extension of a Tax Benefits Preservation Plan to Jan 29, 2028, and auditor fees to Grant Thornton LLP of $660,000 (audit) and $258,447 (tax) for fiscal 2025.

Regis Corporation (RGS) Form 4: The filing reports that Michael Heath Ferranti, Executive Vice President of Brand Operations and a director, was granted and acquired 5,400 shares of common stock with a reported price of $0. After the transaction, Ferranti beneficially owns 13,621 shares. The award vests in three equal annual installments (one‑third on each of the first, second and third anniversaries of the grant date), subject to continued employment and the grant agreement terms. The transaction is recorded as an acquisition of non‑derivative securities and is exempt from cash consideration.

Regis Corporation (RGS) Form 4 shows that James Raymon Suarez, EVP Merchandising & Education, was awarded 5,400 shares of common stock on 09/05/2025 at a reported price of $0, increasing his beneficial ownership to 13,987 shares. The award vests in three equal installments: one-third on each of the first, second and third anniversaries of the grant date, subject to continued employment and grant terms.

The filing was signed by Amy Seidel by power-of-attorney on 09/09/2025. The Form 4 reports a non-derivative acquisition of shares and provides the vesting schedule; no cash purchase or option exercise is reported.

Michelle St. DeVore, Senior Vice President, Marketing at Regis Corporation (RGS), reported an award-based acquisition of 2,500 shares of Regis common stock on 09/05/2025. The transaction price is reported as $0, indicating a grant rather than an open-market purchase. Following the reported transaction, the reporting person beneficially owns 5,000 shares. The award vests in three equal annual tranches: one-third on each of the first, second, and third anniversaries of the grant date, subject to continued employment and the grant terms. The Form 4 was signed by power-of-attorney on 09/09/2025.

Jim Brian Lain, an executive of Regis Corporation (RGS), reported the acquisition of 5,400 shares of Regis common stock on 09/05/2025 under a grant that vested over time. Following the reported transaction, the reporting person beneficially owned 14,588 shares. The grant was recorded with a price of $0, and the filing explains the award vests in three equal installments—one-third on each of the first, second and third anniversaries of the grant date—subject to continued employment and the grant terms. The Form 4 was signed by a power-of-attorney on 09/09/2025.

Regis Corporation (RGS) Chief Financial Officer Kersten Delores Zupfer reported a Form 4 disclosing an award vesting and an ownership correction. On 09/05/2025 the reporting person was issued 5,400 shares of common stock at a $0 price as an award vesting payment. The filing states the award vests in three equal annual installments (1/3 on each of the first, second and third anniversaries of the grant date) subject to continued employment and grant terms.

The Form 4 shows 16,976 shares beneficially owned following the transaction after a reconciliation corrected the reported balance. The form was signed by power-of-attorney on 09/09/2025.